Wormentel Fenbendazole 222mg Tablets

What Is Fenbendazole 222mg?

Fenbendazole 222mg is a benzimidazole anthelmintic compound with decades of established use in veterinary medicine for treating and controlling a broad range of parasitic worm infections in animals.

Fenbendazole does not hold FDA approval for any human medical indication. It is classified primarily as a veterinary antiparasitic compound and must only be used under appropriate professional supervision.

Manufacturer Details

Fenbendazole 222mg Tablets are manufactured by Kachhela Medex Pvt. Ltd., a licensed pharmaceutical manufacturer producing antiparasitic and other medicines in certified facilities operating under recognized Good Manufacturing Practice (GMP) standards.

Kachhela Medex Pvt. Ltd. applies structured quality assurance procedures across every stage of production — from raw material sourcing and formulation through manufacturing, testing, and final packaging. Each batch of Fenbendazole 222mg Tablets undergoes quality evaluation to ensure consistent product purity, potency, and stability in every strip supplied.

The product is packaged in blister strips of 10 tablets per strip, providing protection from moisture and environmental exposure during storage and transit.

How Does Fenbendazole 222mg Work?

Fenbendazole acts through a well-characterized mechanism that selectively targets structural proteins inside susceptible parasitic worm cells.

• It binds specifically to beta-tubulin, a structural protein that parasites depend on to form microtubules
• Microtubules are internal cellular structures essential for nutrient absorption, energy metabolism, and cell division within parasitic organisms
• By binding to beta-tubulin, Fenbendazole disrupts the process of microtubule polymerization — preventing the correct assembly of these structures
• Without functional microtubules, the parasite loses its ability to absorb glucose from the surrounding environment
• As glucose uptake decreases, energy production within the parasite falls progressively
• The parasite becomes weakened, loses structural integrity, and is eventually eliminated naturally from the host body

Fenbendazole demonstrates significantly stronger binding affinity for parasitic beta-tubulin compared to mammalian beta-tubulin — which is the established basis of its selective antiparasitic activity in veterinary use.

Dosage Information

There is no established FDA-approved human dosage for Fenbendazole.

In veterinary practice, appropriate dosage is determined based on:

• Animal species being treated
• Body weight — Fenbendazole dosing is weight-based in most protocols
• Type and severity of parasitic infection
• Treatment protocol and veterinarian assessment

A commonly referenced veterinary protocol involves 3 consecutive daily doses for many gastrointestinal parasitic infections. Some infections may require extended or repeated treatment cycles depending on follow-up parasitological assessment.

For any use considered under healthcare professional supervision, the supervising provider determines the appropriate strength, amount, frequency, and duration based on individual circumstances. Do not independently determine or adjust dosage.

Treatment Duration

Treatment duration depends on the type of parasitic infection and professional assessment. Key points:

• A 3-day consecutive course is commonly referenced for many veterinary parasitic infections
• Some infections may require extended or repeated cycles based on follow-up results
• Stool testing or clinical evaluation may be recommended to confirm successful elimination
• Complete the full prescribed course even when symptoms appear to resolve
• Do not discontinue or extend treatment without professional guidance

Possible Side Effects

Most effects reported in veterinary use are mild and temporary.

Commonly noted in veterinary use:

• Mild digestive upset or nausea
• Temporary loss of appetite
• Diarrhea
• Abdominal discomfort
• Transient lethargy in some animals

In limited supervised human contexts:

• Nausea
• Headache
• Mild stomach discomfort
• Temporary elevation of liver enzyme levels requiring monitoring
• Mild allergic skin reactions

Seek immediate professional attention if:

🚨 Severe allergic reaction — swelling, difficulty breathing, or widespread hives

🚨 Signs of liver involvement — jaundice, dark urine, or persistent unexplained nausea

🚨 Severe or persistent gastrointestinal symptoms

🚨 Suspected overdose — seek veterinary or medical assistance immediately

Contraindications

Do not use Fenbendazole 222mg in the following situations without professional guidance:

• Known hypersensitivity to Fenbendazole or any benzimidazole-class compound
• Previous allergic reactions to related antiparasitic medicines
• Pregnant or breeding animals — only under specific veterinary advice
• Conditions requiring specialized monitoring — as determined by the supervising professional

Warnings & Precautions

• Not FDA-approved for human use — requires direct professional supervision for any non-veterinary application
• Pregnancy and breastfeeding — consult a qualified professional before any use
• Liver impairment — use with caution; monitoring may be required during treatment
• Do not exceed recommended dosage under any circumstances
• Keep out of reach of children and pets at all times
• Disclose all current medications and supplements to the supervising professional before starting treatment
• Follow all professional instructions throughout the complete treatment period

Drug Interactions

Formal drug interaction data for Fenbendazole is limited. Based on currently available information:

• Liver enzyme-metabolized medicines — potential interaction due to Fenbendazole's effect on liver enzyme activity
• Salicylanilide compounds — veterinary literature notes potential for enhanced adverse effects when used concurrently

Always inform the supervising veterinarian or healthcare professional about all medicines, supplements, and products currently in use.

Storage

• Store at room temperature below 25°C or 77°F
• Store in original blister strip packaging until ready for use
• Keep out of reach of children and pets at all times
• Do not use past the printed expiry date
• Dispose of unused or expired tablets per local pharmaceutical waste disposal guidelines

Frequently Asked Questions

Q: What is Fenbendazole 222mg used for?

A: It is commonly referenced in veterinary practice for managing roundworm, hookworm, whipworm, tapeworm, and Giardia infections in animals. Any non-veterinary use must be under direct professional supervision.

Q: Is Fenbendazole 222mg FDA-approved for human use?

A: No. Fenbendazole does not hold FDA approval for any human medical indication. It is classified as a veterinary antiparasitic compound.

Q: Who manufactures Fenbendazole 222mg Tablets?

A: They are manufactured by Kachhela Medex Pvt. Ltd. in GMP-compliant certified pharmaceutical manufacturing facilities.

Q: Why choose the 222mg strength?

A: The 222mg strength is a convenient intermediate option within the Fenbendazole tablet range, allowing accurate weight-based dosing in smaller to medium-weight animals without requiring tablet splitting.

Q: How long does treatment typically last?

A: A 3-day consecutive course is widely referenced for many veterinary parasitic infections. Duration always depends on the specific infection type and professional assessment.

Q: What side effects should be monitored?

A: In veterinary use, mild digestive upset and temporary appetite loss are commonly noted. Seek immediate professional attention for any severe reaction.

Q: How should Fenbendazole 222mg Tablets be stored?

A: Store below 25°C away from sunlight and moisture in the original blister packaging. Keep out of reach of children and pets and do not use past the expiry date.